quinacrine has been researched along with Asthenia in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SCHAMBERG, IL | 1 |
| Huriez, C | 1 |
| Desmons, F | 1 |
| Gautier, G | 1 |
2 other studies available for quinacrine and Asthenia
| Article | Year |
|---|---|
Studies on post-atabrine dermatitis. II. Permanent anhidrosis, anhidrotic asthenia and prolonged dermatitis following atabrine dermatitis.
Topics: Asthenia; Dermatitis; Drug Eruptions; Humans; Hypohidrosis; Quinacrine; Sweating | 1953 |
[Complications with synthetic antimalarials].
Topics: Antimalarials; Asthenia; Central Nervous System Diseases; Chloroquine; Drug Eruptions; Eczema; Eye D | 1969 |